What is MicroGenDX?
Founded in 2008 and headquartered in Lubbock, Texas, MicroGenDX specializes in low-cost, highly accurate qPCR + NGS microbial DNA diagnostics. The company is positioned at the intersection of biotechnology and diagnostics, offering advanced solutions for microbial identification. The recent strategic investment suggests a focus on scaling operations and expanding market reach for its proprietary diagnostic technologies.
How much funding has MicroGenDX raised?
MicroGenDX has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in MicroGenDX
PPP
Public-Private Partnership
What's next for MicroGenDX?
With a substantial enterprise-level funding context, MicroGenDX is poised for significant growth and expansion. The strategic investment indicates a potential for new product development, market penetration, and enhanced operational capabilities. This capital infusion will likely enable MicroGenDX to further solidify its position in the microbial DNA diagnostics sector, potentially exploring new applications or partnerships to leverage its advanced technology.
See full MicroGenDX company page
